Effect of DNA methylation or de-methylation on <i>Pax6</i> gene expression. by Jie Gao (10266)

“…<p><b><i>(A)</i></b> Effect of decreasing DNA methylation on <i>Pax6</i> gene expression in ES cells. …”

Image_1_Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation.jpg by Robert Ossendorff (16653054)

“…These findings were supported by a decrease in matrix differentiation (COL-II). …”

DataSheet_1_Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation.docx by Robert Ossendorff (16653054)

“…These findings were supported by a decrease in matrix differentiation (COL-II). …”

Viral replicative advantages and pathological consequences related to STAT3-altered function. by Armando Andres Roca Suarez (4967134)

“…ANGPTL4, angiopoietin-like protein 4; APR, acute phase response; BIRC5, baculoviral IAP repeat-containing protein 5; CCL5, C-C motif chemokine ligand 5; DCs, dendritic cells; DC-SIGN, dendritic cell-specific ICAM-3-grabbing non-integrin 1; EBV, Epstein–Barr virus; FOS, proto-oncogene c-Fos; HCC, hepatocellular carcinoma; HCMV, human cytomegalovirus; HCV, hepatitis C virus; HEV, hepatitis E virus; HSCs, hepatic stellate cells; IAV, influenza A virus; IDO1, indoleamine 2,3-dioxygenase 1; IL-10, interleukin 10; ISG, interferon-stimulated gene; JUN, proto-oncogene c-Jun; KSHV, Kaposi’s sarcoma-associated herpesvirus; MCL1, induced myeloid leukemia cell differentiation protein Mcl-1; MDSCs, myeloid-derived suppressor cells; MT, microtubule; MUC1, mucin 1 cell surface associated; MuV, mumps virus; NPC, nasopharyngeal carcinoma; NR4A2, nuclear receptor subfamily 4 group A member 2; PCBP2, poly(rC)-binding protein 2; PD-L1, programmed cell death 1 ligand 1; RTA, R transactivator; RVFV, Rift Valley fever virus; STAT3, signal transducer and activator of transcription 3; TGF-β, transforming growth factor beta; T_reg, regulatory CD4⁺ T cell; VZV, varicella-zoster virus.…”

Image_3_Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation.jpg by Robert Ossendorff (16653054)

“…These findings were supported by a decrease in matrix differentiation (COL-II). …”

Image_4_Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation.jpg by Robert Ossendorff (16653054)

“…These findings were supported by a decrease in matrix differentiation (COL-II). …”

Image_2_Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation.jpg by Robert Ossendorff (16653054)

“…These findings were supported by a decrease in matrix differentiation (COL-II). …”

Week 6 & 7 Experimental Design: Impact of the Anthropocene on bug abundance by Naduni Kurukulasooriya (795949)

“…Every 5 meters was considered a new group, the first 5 meters was Group 1 and the last was Group 6. …”

OLE reduces plaque burden in the cortex and hippocampus of TgCRND8 mice. by Cristina Grossi (358570)

“…Both Aβ40 and Aβ42 levels were significantly decreased in OLE-fed Tg versus age-matched untreated Tg (n<i> = </i>5/group) mice. …”

Schematic diagram of the electrochemical detection protocol adopted in this study. by Amanda Giamberardino (484995)

Visualization 1 - Improvement in vascular contrast with an axial displacement of detector.avi by Andres Guevara-Torres (5543636)

Table_2_Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases.DOCX by Nan Lin (26755)

“…Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). …”

Table_1_Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases.DOCX by Nan Lin (26755)

“…Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). …”

Table_2_Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases.DOCX by Nan Lin (26755)

“…Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). …”

Table_1_Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases.DOCX by Nan Lin (26755)

“…Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). …”

Temporal Trend in Young-Onset Type 2 Diabetes - the Macrovascular and Mortality Risk: Study of UK Primary Care Electronic Medical Records by Digsu N. Koye (8881108)

“…The incidence rates of ASCVD and ACM declined in people aged ≥50 years, but did not decrease in people <50 years. Compared to people aged ≥50 years, those aged 18-39 years at diagnosis had higher obesity (71% obese), higher HbA1c (8.6%), 71% had high LDL-C, while only 18% were on cardio-protective therapy. …”

Kinetics of T3 target genes expression in wild-type and <i>TRα^AMI/S</i> mice in the cerebellum as measured by Q-RT-PCR. by Fabrice Chatonnet (37037)

“…<p>Expression levels were calculated for each target gene by Q-RT-PCR in wild-type and <i>TRα^AMI/S</i> littermates at P4, P8, P15 and P21 (minimum 3 animals of each genotype for each time point). Data are expressed as mean ± SD using wild-type P4 values (A), for genes with decreasing or stable expression levels over time or P21 (B), for genes with increasing expression levels, as a reference for each genotype. …”

Zerumbone induced caspase activation subsequent to mitochondrial transmembrane potential loss. by Praveen K. Sobhan (220116)

“…Imaging for Hoechst, TMRM, ECFP, and EYFP FRET were carried out using a 96 well plate Bio-imager as described at the indicated time points. …”

Quantitative Analysis of the Extracellular Response Kinase 1 and 2 (ERK1/2), Calcium-Calmodulin Kinase II (CAMKII), Fragile X Protein (FMRP), and the Nicotinic Acetylcholine Recept... by Robert K. Naviaux (256148)

“…<p>(A) ERK1 (MAPK3) and ERK2 (MAPK1) phosphorylation was decreased by over 90% by gestational poly(IC) exposure and normalized by suramin treatment (Sal-Sal = 100+/−5%; Sal-Sur = 6.2+/−0.8%; PIC-Sal = 9.9+/−2.6%; PIC-Sur = 84+/−2.3%; one-way ANOVA F(3,12) = 241; p<0.0001; n = 4–5 males per group; age = 16 weeks). …”

γδ T cells have similar TCR threshold but enhanced ERK1/2 phosphorylation comparing to αβ T cells. by Hsin-Yuan Cheng (414160)

“…Results were averaged from 5 mice, and shown in mean ± SEM. Lower: Log scaling of αCD3 concentration against % of maximum response was used to calculate EC₅₀. …”